Knowledge Center
Patent / Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Source:
WO 2024009079 A1
The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.
Ìý
Also in the Knowledge Center
/ Feb 02, 2022
Webinar - Process safety evaluation and scale-up resorting to mechanistic modelling for exothermic and gas releasing reactions
Read more
Scientific Article
/ Feb 24, 2022
Webinar - Spray Drying Development: From Lab to Production – How to de-risk your process
Read more
Scientific Article
/ Feb 28, 2023
Webinar - Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management
Read more
Scientific Article